AddLife AB (publ) logo

AddLife AB (publ)

ALIF-B.ST
49
Medical - Instruments & Supplies · Healthcare
Price
kr 160.80
+3.70 (+2.36%)
Market Cap
kr 18.86B
Exchange
Stockholm Stock Exchange
Winston Score
49
Winston looking serious
Winston is serious
Mixed quality — meaningful strengths and weaknesses.

Winston Score between 40 and 70. The stock passes some quality checks but not all.

AddLife AB is a Swedish healthcare company that distributes medical and laboratory equipment across Europe. It sells products like diagnostic tools, surgical instruments, and lab supplies to hospitals, clinics, and research laboratories. The company does not manufacture most of its products — instead, it acts as a middleman between global medical device makers and healthcare customers.

AddLife makes money by buying products from manufacturers and reselling them at a markup, earning a roughly 38% gross margin. It operates mainly in the Nordic countries and broader Europe, with over 100 subsidiary companies acquired over the years through an active acquisition strategy. Its competitive edge comes from deep local market relationships and a decentralized business model that lets each subsidiary operate independently. The main risk is that its growth depends heavily on finding and integrating new acquisitions at reasonable prices — if deal flow slows or integration stumbles, growth could stall.

Winston Score History

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
38.7%
Modest — 38.7% gross margin
Operating Margin
8.7%
Modest — 8.7% operating margin
ROCE
2.2%
Weak — 2.2% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-0.3%
Shrinking sales (-0.3% YoY)
EPS YoY
+83.1%
Earnings growing fast (83.1% YoY)

Earnings growing 25%+ a year. The compounder zone.

EPS Consistency
8/8 quarters
Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
221%
Turns 221% of profit into real cash
FCF Margin
10.8%
Modest free cash flow (10.8%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.85
Moderate — manageable debt (0.85)
Interest Cover
4.90x
Adequate interest coverage (4.9x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio
30.9x
Pricey — P/E 30.9

P/E above the market average. People are paying up for expected growth.

P/E vs Forward
+2.4
GROWING
Earnings expected to grow — slightly cheaper on forward P/E

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
0.98%
Small dividend — 0.98% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend Growth
-36.3%
Dividend cut (-36.3% YoY) — warning sign

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial